Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference
Zimmer Biomet (NYSE: ZBH) announced that members of its management team will present at the 44th Annual J.P.
Rhea-AI Summary
Zimmer Biomet (NYSE: ZBH) announced that members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 8:15 a.m. PT (11:15 a.m. ET).
A live webcast will be available on Zimmer Biomet's Investor Relations website and will be archived for replay after the conference.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ZBH
On Dec 22, the day this news came out, ZBH closed 0.75% above the previous close.
Data tracked by StockTitan Argus for the Dec 22 session.
Key Figures
- Conference date
- January 13, 2026
- J.P. Morgan Healthcare Conference presentation date
- Presentation time (PT)
- 8:15 a.m. PT
- Scheduled start of J.P. Morgan presentation
- Presentation time (ET)
- 11:15 a.m. ET
- Scheduled start of J.P. Morgan presentation
Historical Context
-
Announced a $0.24 per share quarterly cash dividend for Q4 2025.
-
Exclusive collaboration with OneStep to add mobility analytics to mymobility.
-
Received U.S. FDA 510(k) clearance for enhanced ROSA Knee with OptimiZe.
-
Announced participation and webcast for Jefferies Global Healthcare Conference.
-
Reported Q3 2025 results with higher sales and acquisitions; shares fell sharply.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. The webcast will be archived for replay following the conference.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
Contacts: Media Troy Kirkpatrick 614-284-1926 troy.kirkpatrick@zimmerbiomet.com
781-779-5561 | Investors David DeMartino 646-531-6115 david.demartino@zimmerbiomet.com
908-591-6955 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302647147.html
SOURCE Zimmer Biomet Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.